CN102068529A - Traditional Chinese medicine for treatment of prostatic hyperplasia - Google Patents
Traditional Chinese medicine for treatment of prostatic hyperplasia Download PDFInfo
- Publication number
- CN102068529A CN102068529A CN2010102857406A CN201010285740A CN102068529A CN 102068529 A CN102068529 A CN 102068529A CN 2010102857406 A CN2010102857406 A CN 2010102857406A CN 201010285740 A CN201010285740 A CN 201010285740A CN 102068529 A CN102068529 A CN 102068529A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- treatment
- prostatic hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for the treatment of prostatic hyperplasia, which belongs to the field of traditional Chinese medicines for treating the diseases in urinary system and which has good effect and takes effect rapidly; the traditional Chinese medicine is prepared from the raw materials including oyster, angelica, ganoderma lucidum, radix salviae miltiorrhizae, notoginseng, Chinese pink herb, gardenia and the like; the traditional Chinese medicine has the effects of strengthening body resistance, restoring normal function of body, supplementing qi, nourishing blood, promoting blood circulation, removing blood stasis, inducing diuresis to alleviate edema, excreting dampness and treating stranguria, and has the advantages of obvious and exact therapeutic effect and fast effect taking.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
18 parts of 6-18 parts of Radix Angelicae Sinensis of Concha Ostreae 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---15 parts of 18 portions of Radix Notoginseng 3---9 portions of Herba Dianthis 5---
Fructus Gardeniae 5---15 parts
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Concha Ostreae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Be aided with Concha Ostreae hard masses softening and resolving; Herba Dianthi, Fructus Gardeniae inducing diuresis for treating stranguria syndrome, Herba Dianthi clearing heat and freeing strangury removing heat from blood, the diuresis of Fructus Gardeniae heat clearing and blood cooling, the two 5 be a usefulness mutually, effect that heat clearing and blood cooling is treating stranguria enhancing is used for the treatment of urinary obstruction, the odynuria effect is distinguished.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, the merit that eliminating dampness by diuresis is treating stranguria, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Concha Ostreae 60 gram Radix Angelicae Sinensis 60 kairine sesames 60 grams
Radix Salviae Miltiorrhizae 60 gram Radix Notoginseng 30 gram Herba Dianthis 50 grams
Fructus Gardeniae 50 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Concha Ostreae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted, make extract fine powder 68 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 350 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Concha Ostreae 120 gram Radix Angelicae Sinensis 120 kairine sesames 120 grams
Radix Salviae Miltiorrhizae 120 gram Radix Notoginseng 60 gram Herba Dianthis 100 grams
Fructus Gardeniae 100 grams
By above-mentioned same method, make 700 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Concha Ostreae 180 gram Radix Angelicae Sinensis 180 kairine sesames 180 grams
Radix Salviae Miltiorrhizae 180 gram Radix Notoginseng 90 gram Herba Dianthis 150 grams
Fructus Gardeniae 150 grams
By above-mentioned same method, make 1050 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 portions of Ganodermas of 7 parts of Radix Angelicae Sinensis of Concha Ostreae
6 parts of 3 portions of Herba Dianthis of 7 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
6 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 15 portions of Ganodermas of 15 parts of Radix Angelicae Sinensis of Concha Ostreae
12 parts of 7 portions of Herba Dianthis of 15 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
12 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-81 years old, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. Chinese medicine for the treatment of prostatic hyperplasia, it is characterized in that: it is to make with the component of following weight ratio: Concha Ostreae 6---18 parts, Radix Angelicae Sinensis 6---18 parts, Ganoderma 6---18 parts, Radix Salviae Miltiorrhizae 6---18 parts, Radix Notoginseng 3---9 parts, Herba Dianthi 5---15 parts, Fructus Gardeniae 5---15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102857406A CN102068529A (en) | 2010-09-16 | 2010-09-16 | Traditional Chinese medicine for treatment of prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102857406A CN102068529A (en) | 2010-09-16 | 2010-09-16 | Traditional Chinese medicine for treatment of prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102068529A true CN102068529A (en) | 2011-05-25 |
Family
ID=44027407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102857406A Pending CN102068529A (en) | 2010-09-16 | 2010-09-16 | Traditional Chinese medicine for treatment of prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102068529A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102380023A (en) * | 2011-07-29 | 2012-03-21 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasia |
| CN102389525A (en) * | 2011-09-16 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for curing benign prostatic hyperplasia |
| CN102670787A (en) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating prostatoplasia |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872207A (en) * | 2006-04-21 | 2006-12-06 | 潘佩光 | Enema of Chinese traditional medicine for treating chronic prostatitis in type of congestion |
-
2010
- 2010-09-16 CN CN2010102857406A patent/CN102068529A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872207A (en) * | 2006-04-21 | 2006-12-06 | 潘佩光 | Enema of Chinese traditional medicine for treating chronic prostatitis in type of congestion |
Non-Patent Citations (2)
| Title |
|---|
| 刘晶晶: "植物药治疗前列腺增生症的研究进展", 《天津中医药大学学报》, vol. 29, no. 2, 15 June 2010 (2010-06-15), pages 111 - 112 * |
| 谷银强等: "中医药治疗良性前列腺增生症研究进展", 《河北中医药学报》, vol. 20, no. 4, 30 December 2005 (2005-12-30), pages 32 - 35 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102380023A (en) * | 2011-07-29 | 2012-03-21 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasia |
| CN102389525A (en) * | 2011-09-16 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for curing benign prostatic hyperplasia |
| CN102670787A (en) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating prostatoplasia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN102114172A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102389530A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102068594A (en) | Chinese medicament for treating chronic prostatitis | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102327350A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN102389522A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101953937A (en) | Chinese medicament for treating chronic prostatitis | |
| CN102380023A (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102389525A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102389523A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102631459A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102389531A (en) | Traditional Chinese medicine for curing chronic prostatitis | |
| CN101972426A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102068569A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102139009A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102114080A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101961416A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101983648A (en) | Traditional Chinese medicine for treating prostatic hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110525 |